Related Experiment Video
Updated: Jun 27, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective
Maura Ravera1, Giuseppe Noberasco, Michela Re
1Division of Nephrology, Dialysis and Transplantation, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Insights
Chronic kidney disease (CKD) is common in hypertensive type 2 diabetes patients, significantly increasing cardiovascular risk. Early detection by general practitioners is crucial for improving outcomes in this high-risk population.
Area of Science:
- Nephrology
- Cardiology
- Primary Care Medicine
Background:
- Chronic kidney disease (CKD) is linked to adverse renal and cardiovascular (CV) outcomes.
- Early CKD identification relies heavily on general practitioners' (GPs) awareness.
- Limited research exists on CKD prevalence in primary care, especially in hypertensive diabetics.
Purpose of the Study:
- To assess the prevalence of CKD in hypertensive type 2 diabetic patients.
- To investigate the association between CKD and cardiovascular (CV) morbidity in this population.
Main Methods:
- Utilized data from an Italian national project involving GPs and nephrologists.
- Analyzed demographic, laboratory, and clinical data of 7582 hypertensive type 2 diabetics.
- Calculated estimated glomerular filtration rate (eGFR) using the MDRD equation; CKD defined as eGFR < 60 mL/min/1.73 m².
Main Results:
- CKD prevalence was 26%, with GPs diagnosing it in only 5.4% of cases.
- Prevalence of left ventricular hypertrophy (LVH) and major CV events was 8%.
- Patients with CKD exhibited higher rates of LVH and CV events, with a 23% increased risk for every 21 mL/min/1.73 m² decrease in eGFR.
Conclusions:
- CKD is highly prevalent and a strong predictor of adverse CV outcomes in hypertensive type 2 diabetics.
- GP awareness of CKD in this population is notably low.
- Integrating eGFR calculation into GP databases is recommended for early CKD detection and improved CV outcomes.
Background:
Chronic kidney disease (CKD) is associated with poor renal and cardiovascular (CV) outcome, and early identification largely depends on the general practitioners' (GPs) awareness of it. Only a few studies have evaluated the prevalence of CKD in type 2 diabetes in primary care, and no studies are available on hypertensive diabetics. Thus, the aim of this study was to assess the prevalence of CKD and its association with CV morbidity in such a population.
Methods:
On the basis of an Italian national project involving GPs and nephrologists, we retrieved demographic, laboratory and clinical data regarding 7582 hypertensive type 2 diabetics (3564 men; age 25-89 years) who were selected using the diagnostic code Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) for diabetes and hypertension. Blood pressure (BP) values, serum creatinine, ECG-diagnosed left ventricular hypertrophy (LVH) and the occurrence of previous major CV events were obtained for each patient from the GPs' Health Search Database. Estimated glomerular filtration rate (GFR) was calculated according to the four-variable MDRD equation. CKD was defined as an estimated GFR < 60 mL/min/ 1.73 m2.
Results:
CKD prevalence was 26%, although renal disease was diagnosed by GPs in only 5.4% of cases. The prevalence of both LVH and major CV events was 8%. Adequate BP control was only achieved in 10.4% of patients. Patients whose GFR was <60 mL/min/1.73 m2 were older, prevalently female, had increased pulse pressure and higher prevalence of dyslipidaemia. Moreover, the prevalence of both LVH and major CV events was higher in patients with CKD as compared to patients with normal GFR. Multivariate logistic regression analysis showed that patients with CKD had a higher risk of LVH and/or CV events adjusted for eight covariates, and this risk increased by 23% with each 21 mL/min/1.73 m2 decrease in GFR.
Conclusions:
This study shows that CKD is highly prevalent in hypertensive type 2 diabetic patients, where it is a strong predictor of CV adverse outcome. However, awareness of CKD by GPs is low. Equations for calculating estimated GFR should be included in the GPs' database in order to detect the presence of CKD and to improve CV outcome of such a high-risk population.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction
